- Home
- DMA vs INCR Comparison
DMA vs INCR Comparison
Compare DMA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMA
- INCR
- Stock Information
- Founded
- DMA 2011
- INCR 1994
- Country
- DMA United States
- INCR Israel
- Employees
- DMA N/A
- INCR N/A
- Industry
- DMA Trusts Except Educational Religious and Charitable
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- DMA Finance
- INCR Health Care
- Exchange
- DMA Nasdaq
- INCR Nasdaq
- Market Cap
- DMA 77.8M
- INCR 84.5M
- IPO Year
- DMA N/A
- INCR N/A
- Fundamental
- Price
- DMA $8.59
- INCR $1.51
- Analyst Decision
- DMA
- INCR
- Analyst Count
- DMA 0
- INCR 0
- Target Price
- DMA N/A
- INCR N/A
- AVG Volume (30 Days)
- DMA 34.6K
- INCR 37.2K
- Earning Date
- DMA 01-01-0001
- INCR 08-15-2025
- Dividend Yield
- DMA 2.04%
- INCR N/A
- EPS Growth
- DMA N/A
- INCR N/A
- EPS
- DMA N/A
- INCR N/A
- Revenue
- DMA N/A
- INCR $65,575,323.00
- Revenue This Year
- DMA N/A
- INCR $69.54
- Revenue Next Year
- DMA N/A
- INCR $41.75
- P/E Ratio
- DMA N/A
- INCR N/A
- Revenue Growth
- DMA N/A
- INCR N/A
- 52 Week Low
- DMA $4.78
- INCR $1.17
- 52 Week High
- DMA $8.00
- INCR $2.44
- Technical
- Relative Strength Index (RSI)
- DMA 45.61
- INCR 46.99
- Support Level
- DMA $8.44
- INCR $1.48
- Resistance Level
- DMA $8.71
- INCR $1.57
- Average True Range (ATR)
- DMA 0.11
- INCR 0.05
- MACD
- DMA -0.02
- INCR -0.00
- Stochastic Oscillator
- DMA 43.66
- INCR 18.75
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.